ofloxacin has been researched along with Bacterial Conjunctivitides in 19 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "3% levofloxacin eyedrops on the treatment of acute bacterial conjunctivitis and bacterial keratitis." | 9.09 | [Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis]. ( Chen, F; Hu, Y; Zhang, M, 2000) |
| " In this study we investigate the emergence of fluoroquinolone (ciprofloxacin, levofloxacin) resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis." | 7.72 | Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. ( Alfonso, EC; Marangon, FB; Miller, D; Muallem, MS; Romano, AC, 2004) |
| "The aim of the study was to estimate changes in bacterial flora of conjunctival sac changes in patients prophylacticaly treated with different antibiotics (chloramphenicol, gentamycin, ofloxacin, norfloxacin) before cataract operation." | 5.11 | [Changes in bacterial flora of conjunctival sac in patients prophylacticaly treated with antibiotic before cataract operation]. ( Gerkowicz, M; Gruszecka-Gerkowicz, R; Kosior-Jarecka, E; Pietraś-Trzpiel, M, 2005) |
| "3% levofloxacin eyedrops on the treatment of acute bacterial conjunctivitis and bacterial keratitis." | 5.09 | [Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis]. ( Chen, F; Hu, Y; Zhang, M, 2000) |
| " In this study we investigate the emergence of fluoroquinolone (ciprofloxacin, levofloxacin) resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis." | 3.72 | Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. ( Alfonso, EC; Marangon, FB; Miller, D; Muallem, MS; Romano, AC, 2004) |
| "The gatifloxacin eye drop has a good therapeutic effect to the bacterial conjunctivitis." | 2.75 | [Comparative research of the efficacy of the gatifloxacin and levofloxacin for bacterial conjunctivitis in human eyes]. ( Gong, L; Qiu, XD; Qu, J; Sun, XH; Xiong, QC; Yuan, ZL; Zhang, YQ, 2010) |
| "5% levofloxacin ophthalmic solution was found to be safe and effective in treating pediatric bacterial conjunctivitis." | 2.71 | Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients. ( Lichtenstein, SJ; Rinehart, M, 2003) |
| "Ofloxacin was found as effective, safe, and comfortable as tobramycin in patients with external ocular infection and may provide earlier symptom relief." | 2.67 | Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II. ( Gwon, A, 1992) |
| "Gatifloxacin showed lower resistance levels than moxifloxacin." | 1.38 | [In vitro antibiotic susceptibility to fluoroquinolones]. ( Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Arienzo, PA | 1 |
| Wagner, RS | 1 |
| Jamison, T | 1 |
| Bell, B | 1 |
| Dajcs, JJ | 1 |
| Stroman, DW | 1 |
| Kodjikian, L | 1 |
| Lafuma, A | 1 |
| Khoshnood, B | 1 |
| Laurendeau, C | 1 |
| Berdeaux, G | 1 |
| Gong, L | 1 |
| Sun, XH | 1 |
| Qiu, XD | 1 |
| Zhang, YQ | 1 |
| Qu, J | 1 |
| Yuan, ZL | 1 |
| Xiong, QC | 1 |
| Wong, CA | 1 |
| Galvis, V | 1 |
| Tello, A | 1 |
| Villareal, D | 1 |
| Rey, JJ | 1 |
| Nettis, E | 1 |
| Giordano, D | 1 |
| Pierluigi, T | 1 |
| Ferrannini, A | 1 |
| Tursi, A | 1 |
| Zhang, M | 1 |
| Hu, Y | 1 |
| Chen, F | 1 |
| Schwab, IR | 1 |
| Friedlaender, M | 1 |
| McCulley, J | 1 |
| Lichtenstein, SJ | 2 |
| Moran, CT | 1 |
| Hwang, DG | 2 |
| Schanzlin, DJ | 1 |
| Rotberg, MH | 1 |
| Foulks, G | 1 |
| Raizman, MB | 1 |
| Rinehart, M | 1 |
| Marangon, FB | 1 |
| Miller, D | 1 |
| Muallem, MS | 1 |
| Romano, AC | 1 |
| Alfonso, EC | 1 |
| Gerkowicz, M | 1 |
| Gruszecka-Gerkowicz, R | 1 |
| Kosior-Jarecka, E | 1 |
| Pietraś-Trzpiel, M | 1 |
| Qi, CX | 1 |
| Wu, XM | 1 |
| Wang, XL | 1 |
| Zhang, W | 1 |
| Wu, Y | 1 |
| Zhao, J | 1 |
| Lin, B | 1 |
| Su, X | 1 |
| Friedlaender, MH | 1 |
| Snyder-Perlmutter, LS | 1 |
| Katz, HR | 1 |
| Melia, M | 1 |
| Graves, A | 1 |
| Henry, M | 1 |
| O'Brien, TP | 1 |
| Van Buskirk, A | 1 |
| Trousdale, MD | 1 |
| Wittpenn, JR | 1 |
| Gwon, A | 1 |
1 review available for ofloxacin and Bacterial Conjunctivitides
| Article | Year |
|---|---|
[Efficacy of moxifloxacin in treating bacterial conjunctivitis: a meta-analysis].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Conjunctivitis, Bacterial; Double-Blind | 2010 |
12 trials available for ofloxacin and Bacterial Conjunctivitides
| Article | Year |
|---|---|
[Comparative research of the efficacy of the gatifloxacin and levofloxacin for bacterial conjunctivitis in human eyes].
Topics: Adolescent; Adult; Conjunctivitis, Bacterial; Double-Blind Method; Female; Fluoroquinolones; Gatiflo | 2010 |
[Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Conjunctivitis, Bacterial; Eye Infections, Bacterial | 2000 |
A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria; Child; Child, Preschool | 2003 |
A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Child, Preschool; Conjunct | 2003 |
Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients.
Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Conjunctivitis, Bacterial; Dose-Response | 2003 |
[Changes in bacterial flora of conjunctival sac in patients prophylacticaly treated with antibiotic before cataract operation].
Topics: Antibiotic Prophylaxis; Cataract; Cataract Extraction; Chloramphenicol; Conjunctiva; Conjunctivitis, | 2005 |
[Clinical research of isatis root eyedrops on the acute bacterial conjunctivitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Conjunctivitis, Bacterial; Double-Blind Method; Drug | 2007 |
Rapid diagnosis and treatment of chlamydial conjunctivitis.
Topics: Adolescent; Adult; Antigens, Bacterial; Child; Chlamydia trachomatis; Conjunctivitis, Bacterial; Enz | 1995 |
[The clinical observation of China-made ofloxacin eye drops in the treatment of bacterial infection of the external eye].
Topics: Adult; Aged; Conjunctivitis, Bacterial; Hordeolum; Humans; Middle Aged; Ofloxacin; Ophthalmic Soluti | 1994 |
Twice-a-day versus four-times-a-day ofloxacin treatment of external ocular infection.
Topics: Administration, Topical; Anti-Infective Agents; Bacteria; Blepharitis; Colony Count, Microbial; Conj | 1998 |
Effect of topical ciprofloxacin 0.3% and ofloxacin 0.3% on the reduction of bacterial flora on the human conjunctiva.
Topics: Alcaligenes; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Conjunctiva; Conjunctivi | 2000 |
Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II.
Topics: Blepharitis; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Corneal Ulcer; Double- | 1992 |
6 other studies available for ofloxacin and Bacterial Conjunctivitides
| Article | Year |
|---|---|
Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteriological Techniques; Ciprofloxacin; Conjunctivitis, Bac | 2010 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; | 2012 |
Erythema multiforme-like rash in a patient sensitive to ofloxacin.
Topics: Adrenal Cortex Hormones; Adult; Conjunctivitis, Bacterial; Drug Hypersensitivity; Drug Therapy, Comb | 2002 |
Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Conjunctivitis, Bacterial; Cross-Sectional Studies; Drug Resis | 2004 |
In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Conjunctivitis, Bacterial; | 2001 |
Effect of ciprofloxacin and ofloxacin on bacterial flora.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Conjunctiva; Conjunctivitis | 2001 |